ERBB2 and breast cancer: In women, the most common cause of brain metastasis is breast cancer, with human epidermal growth factor receptor 2 (HER2) overexpression being a major risk factor for a reduced brain metastasis-free survival 3, 4 and a significantly reduced overall survival 3, 5.